Deep Venous Disease Treatment Devices Market - A Global and Regional Analysis: Focus on Product, End User and Country Analysis - Analysis and Forecast, 2023-2032

Table of Contents

1 Markets

• 1.1 Global Market Outlook
  • 1.1.1 Product Definition
  • 1.1.2 Inclusion and Exclusion Criteria
  • 1.1.3 Key Findings
  • 1.1.4 Global Market Scenario
    • 1.1.4.1 Realistic Growth Scenario
    • 1.1.4.2 Optimistic Scenario
    • 1.1.4.3 Pessimistic Scenario
• 1.2 Industry Outlook
  • 1.2.1 Key Trends
    • 1.2.1.1 Rise in the Number of Regulatory Approvals and Legal Activities of Products and Devices for Deep Venous Disease Treatment
    • 1.2.1.2 Upsurge in the Use of Non-Invasive and Minimally Invasive Techniques to Treat and Prevent Deep Venous Diseases
  • 1.2.2 Patent Analysis
    • 1.2.2.1 Awaited Technological Developments
    • 1.2.2.2 Patent Filing Trend (by Year)
    • 1.2.2.3 Patent Filing Trend (by Region)
  • 1.2.3 Product Benchmarking
  • 1.2.4 Ongoing Clinical Trial Analysis
  • 1.2.5 Product Pipeline
  • 1.2.6 Regulatory Scenario
    • 1.2.6.1 U.S. Food and Drugs Administration (U.S. FDA)
    • 1.2.6.2 European Medicines Agency (EMA)
    • 1.2.6.3 National Medical Products Administration (NMPA)
    • 1.2.6.4 Pharmaceuticals and Medical Devices Agency (PMDA)
• 1.3 Impact of COVID-19 on Deep Venous Disease Treatment Devices Market
  • 1.3.1 Impact on Deep Venous Disease Treatment Devices
  • 1.3.2 Impact on New Product Launches by Market Players
  • 1.3.3 Impact on Market Size
    • 1.3.3.1 Pre-COVID-19 Phase
    • 1.3.3.2 During COVID-19 Phase
    • 1.3.3.3 Post-COVID-19 Phase
• 1.4 Business Dynamics
  • 1.4.1 Impact Analysis
  • 1.4.2 Business Drivers
    • 1.4.2.1 Upsurge in Incidence of Deep Vein Diseases Leading to Increased Demand for Treatment Devices
    • 1.4.2.2 Increasing Awareness of Preventative Devices Leading to the Growth of Deep Venous Disease Devices in the Market
    • 1.4.2.3 Rise in Diagnosis of Deep Venous Diseases in Hospitals Leading to Increased Use of Treatment Devices
  • 1.4.3 Business Restraints
    • 1.4.3.1 Rise in Drug-Based Treatment for Deep Venous Diseases Hindering the Adoption of Surgical Devices
    • 1.4.3.2 Lack of Skilled Professionals Performing Vascular Surgery Expected to Hinder the Market of Surgical Treatment Devices
  • 1.4.4 Business Opportunities
    • 1.4.4.1 Development of Patient Specific Vascular Stents
    • 1.4.4.2 Development of Advanced Intermittent Pneumatic Compression (IPC) Device for Prophylaxis of Diseases.

2 Global Deep Venous Disease Treatment Devices Market (by Product)

• 2.1 Opportunity Assessment
• 2.2 Growth-Share Matrix
• 2.3 Thrombectomy and Thrombolysis Device
  • 2.3.1 Market Dynamics
  • 2.3.2 Competitive Analysis
  • 2.3.3 Market Size and Forecast
    • 2.3.3.1 Thrombectomy and Thrombolysis Device (by Device)
• 2.4 Inferior Vena Cava (IVC) Filter
  • 2.4.1 Market Dynamics
  • 2.4.2 Competitive Analysis
  • 2.4.3 Market Size and Forecast
    • 2.4.3.1 Inferior Vena Cava Filter (by Device)
• 2.5 Peripheral Vascular Stent
  • 2.5.1 Market Dynamics
  • 2.5.2 Competitive Analysis
  • 2.5.3 Market Size and Forecast
    • 2.5.3.1 Peripheral Vascular Stent (by Type)
• 2.6 PTA Balloon Catheter
  • 2.6.1 Market Dynamics
  • 2.6.2 Competitive Analysis
  • 2.6.3 Market Size and Forecast
    • 2.6.3.1 PTA Balloon Catheter (by Material)
• 2.7 Accessory Device
  • 2.7.1 Competitive Analysis
  • 2.7.2 Market Size and Forecast
    • 2.7.2.1 Accessory Device (by Type)
• 2.8 Compression Device/Stockings
  • 2.8.1 Market Dynamics
  • 2.8.2 Competitive Analysis
  • 2.8.3 Market Size and Forecast

3 Global Deep Venous Disease Treatment Devices Market (by End User)

• 3.1 Opportunity Assessment
• 3.2 Growth-Share Matrix
• 3.3 Hospitals and Clinics
• 3.4 Ambulatory Surgery Centers
• 3.5 Home-Care

4 Region

• 4.1 North America Deep Venous Disease Treatment Devices Market
  • 4.1.1 Key Findings and Opportunity Assessment
  • 4.1.2 Market Dynamics
    • 4.1.2.1 Impact Analysis
  • 4.1.3 Market Sizing and Forecast
    • 4.1.3.1 North America Deep Venous Disease Treatment Devices Market (by Product Type)
    • 4.1.3.2 North America Deep Venous Disease Treatment Devices Market (by End User)
    • 4.1.3.3 North America Deep Venous Disease Treatment Devices Market (by Country)
      • 4.1.3.3.1 U.S.
        • 4.1.3.3.1.1 U.S. Deep Venous Disease Treatment Devices Market (by Product Type)
        • 4.1.3.3.1.2 U.S. Deep Venous Disease Treatment Devices Market (by End User)
      • 4.1.3.3.2 Canada
        • 4.1.3.3.2.1 Canada Deep Venous Disease Treatment Devices Market (by Product Type)
        • 4.1.3.3.2.2 Canada Deep Venous Disease Treatment Devices Market (by End User)
• 4.2 Europe Deep Venous Disease Treatment Devices Market
  • 4.2.1 Key Findings and Opportunity Assessment
  • 4.2.2 Market Dynamics
    • 4.2.2.1 Impact Analysis
  • 4.2.3 Market Sizing and Forecast
    • 4.2.3.1 Europe Deep Venous Disease Treatment Devices Market (by Product Type)
    • 4.2.3.2 Europe Deep Venous Disease Treatment Devices Market (by End User)
    • 4.2.3.3 Europe Deep Venous Disease Treatment Devices Market (by Country)
      • 4.2.3.3.1 Germany
        • 4.2.3.3.1.1 Germany Deep Venous Disease Treatment Devices Market (by Product Type)
        • 4.2.3.3.1.2 Germany Deep Venous Disease Treatment Devices Market (by End User)
      • 4.2.3.3.2 U.K.
        • 4.2.3.3.2.1 U.K. Deep Venous Disease Treatment Devices Market (by Product Type)
        • 4.2.3.3.2.2 U.K. Deep Venous Disease Treatment Devices Market (by End User)
      • 4.2.3.3.3 France
        • 4.2.3.3.3.1 France Deep Venous Disease Treatment Devices Market (by Product Type)
        • 4.2.3.3.3.2 France Deep Venous Disease Treatment Devices Market (by End User)
      • 4.2.3.3.4 Italy
        • 4.2.3.3.4.1 Italy Deep Venous Disease Treatment Devices Market (by Product Type)
        • 4.2.3.3.4.2 Italy Deep Venous Disease Treatment Devices Market (by End User)
      • 4.2.3.3.5 Spain
        • 4.2.3.3.5.1 Spain Deep Venous Disease Treatment Devices Market (by Product Type)
        • 4.2.3.3.5.2 Spain Deep Venous Disease Treatment Devices Market (by End User)
      • 4.2.3.3.6 Rest-of-Europe
        • 4.2.3.3.6.1 Rest-of-Europe Deep Venous Disease Treatment Devices Market (by Product Type)
        • 4.2.3.3.6.2 Rest-of-Europe Deep Venous Disease Treatment Devices Market (by End User)
• 4.3 Asia-Pacific Deep Venous Disease Treatment Devices Market
  • 4.3.1 Key Findings and Opportunity Assessment
  • 4.3.2 Market Dynamics
    • 4.3.2.1 Impact Analysis
  • 4.3.3 Market Sizing and Forecast
    • 4.3.3.1 Asia-Pacific Deep Venous Disease Treatment Devices Market (by Product Type)
    • 4.3.3.2 Asia-Pacific Deep Venous Disease Treatment Devices Market (by End User)
    • 4.3.3.3 Asia-Pacific Deep Venous Disease Treatment Devices Market (by Country)
      • 4.3.3.3.1 Japan
        • 4.3.3.3.1.1 Japan Deep Venous Disease Treatment Devices Market (by Product Type)
        • 4.3.3.3.1.2 Japan Deep Venous Disease Treatment Devices Market (by End User)
      • 4.3.3.3.2 China
        • 4.3.3.3.2.1 China Deep Venous Disease Treatment Devices Market (by Product Type)
        • 4.3.3.3.2.2 China Deep Venous Disease Treatment Devices Market (by End User)
      • 4.3.3.3.3 India
        • 4.3.3.3.3.1 India Deep Venous Disease Treatment Devices Market (by Product Type)
        • 4.3.3.3.3.2 India Deep Venous Disease Treatment Devices Market (by End User)
      • 4.3.3.3.4 Australia
        • 4.3.3.3.4.1 Australia Deep Venous Disease Treatment Devices Market (by Product Type)
        • 4.3.3.3.4.2 Australia Deep Venous Disease Treatment Devices Market (by End User)
      • 4.3.3.3.5 South Korea
        • 4.3.3.3.5.1 South Korea Deep Venous Disease Treatment Devices Market (by Product Type)
        • 4.3.3.3.5.2 South Korea Deep Venous Disease Treatment Devices Market (by End User)
      • 4.3.3.3.6 Rest-of-Asia-Pacific
        • 4.3.3.3.6.1 Rest-of-Asia-Pacific Deep Venous Disease Treatment Devices Market (by Product Type)
        • 4.3.3.3.6.2 Rest-of-Asia-Pacific Deep Venous Disease Treatment Devices Market (by End User)
• 4.4 Rest-of-the-World Deep Venous Disease Treatment Devices Market
  • 4.4.1 Key Findings and Opportunity Assessment
  • 4.4.2 Market Dynamics
    • 4.4.2.1 Impact Analysis
  • 4.4.3 Market Sizing and Forecast
    • 4.4.3.1 Rest-of-the-World Deep Venous Disease Treatment Devices Market (by Product Type)
    • 4.4.3.2 Rest-of-the-World Deep Venous Disease Treatment Devices Market (by End User)
    • 4.4.3.3 Rest-of-the-World Deep Venous Disease Treatment Devices Market (by Country)
      • 4.4.3.3.1 Brazil
        • 4.4.3.3.1.1 Brazil Deep Venous Disease Treatment Devices Market (by Product Type)
        • 4.4.3.3.1.2 Brazil Deep Venous Disease Treatment Devices Market (by End User)
      • 4.4.3.3.2 South Africa
        • 4.4.3.3.2.1 South Africa Deep Venous Disease Treatment Devices Market (by Product Type)
        • 4.4.3.3.2.2 South Africa Deep Venous Disease Treatment Devices Market (by End User)
      • 4.4.3.3.3 Rest-of-Rest-of-the-World
        • 4.4.3.3.3.1 Rest-of-Rest-of-the-World Deep Venous Disease Treatment Devices Market (by Product Type)
        • 4.4.3.3.3.2 Rest-of-Rest-of-the-World Deep Venous Disease Treatment Devices Market (by End User)

5 Markets - Competitive Benchmarking & Company Profiles

• 5.1 Competitive Landscape
  • 5.1.1 Key Strategies and Developments
    • 5.1.1.1 Regulatory and Legal Activities
    • 5.1.1.2 Partnerships, Alliances, and Business Expansions
    • 5.1.1.3 New Offerings
    • 5.1.1.4 Mergers and Acquisitions
    • 5.1.1.5 Funding Activities
  • 5.1.2 Key Development Analysis (Heat Map)
• 5.2 Company Profiles
  • 5.2.1 Abbott Laboratories
    • 5.2.1.1 Company Overview
    • 5.2.1.2 Role of Abbott Laboratories in the Global Deep Venous Disease Treatment Devices Market
    • 5.2.1.3 Product Portfolio
    • 5.2.1.4 Financials
    • 5.2.1.5 Recent Developments
    • 5.2.1.6 Analyst Perspectives
  • 5.2.2 AndraTec GmbH
    • 5.2.2.1 Company Overview
    • 5.2.2.2 Role of AndraTec GmbH in the Deep Venous Disease Treatment Devices Market
    • 5.2.2.3 Product Portfolio
    • 5.2.2.4 Recent Developments
    • 5.2.2.5 Analyst Perception
  • 5.2.3 AngioDynamics, Inc.
    • 5.2.3.1 Company Overview
    • 5.2.3.2 Role of AngioDynamics, Inc. in the Deep Venous Disease Treatment Devices Market
    • 5.2.3.3 Product Portfolio
    • 5.2.3.4 Financials
    • 5.2.3.5 Recent Developments
    • 5.2.3.6 Analyst Perception
  • 5.2.4 Boston Scientific Corporation
    • 5.2.4.1 Company Overview
    • 5.2.4.2 Role of Boston Scientific Corporation in the Deep Venous Disease Treatment Devices Market
    • 5.2.4.3 Product Portfolio
    • 5.2.4.4 Financials
    • 5.2.4.5 Recent Developments
    • 5.2.4.6 Analyst Perception
  • 5.2.5 Cardinal Health
    • 5.2.5.1 Company Overview
    • 5.2.5.2 Role of Cardinal Health in the Deep Venous Disease Treatment Devices Market
    • 5.2.5.3 Product Portfolio
    • 5.2.5.4 Financials
    • 5.2.5.5 Analyst Perception
  • 5.2.6 Cook Group
    • 5.2.6.1 Company Overview
    • 5.2.6.2 Role of Cook Group in the Deep Venous Disease Treatment Devices Market
    • 5.2.6.3 Product Portfolio
    • 5.2.6.4 Recent Developments
    • 5.2.6.5 Analyst Perception
  • 5.2.7 Innova Vascular, Inc.
    • 5.2.7.1 Company Overview
    • 5.2.7.2 Role of Innova Vascular, Inc. in the Deep Venous Disease Treatment Devices Market
    • 5.2.7.3 Recent Developments
    • 5.2.7.4 Analyst Perception
  • 5.2.8 Koninklijke Philips N.V.
    • 5.2.8.1 Company Overview
    • 5.2.8.2 Role of Koninklijke Philips N.V. in the Deep Venous Disease Treatment Devices Market
    • 5.2.8.3 Product Portfolio
    • 5.2.8.4 Financials
    • 5.2.8.5 Recent Developments
    • 5.2.8.6 Analyst Perception
  • 5.2.9 Medtronic plc
    • 5.2.9.1 Company Overview
    • 5.2.9.2 Role of Medtronic plc in the Deep Venous Disease Treatment Devices Market
    • 5.2.9.3 Product Portfolio
    • 5.2.9.4 Financials
    • 5.2.9.5 Recent Developments
    • 5.2.9.6 Analyst Perception
  • 5.2.10 Nipro Corporation
    • 5.2.10.1 Company Overview
    • 5.2.10.2 Role of Nipro Corporation in the Deep Venous Disease Treatment Devices Market
    • 5.2.10.3 Product Portfolio
    • 5.2.10.4 Financials
    • 5.2.10.5 Recent Developments
    • 5.2.10.6 Analyst Perception
  • 5.2.11 Penumbra, Inc.
    • 5.2.11.1 Company Overview
    • 5.2.11.2 Role of Penumbra, Inc. in the Deep Venous Disease Treatment Devices Market
    • 5.2.11.3 Product Portfolio
    • 5.2.11.4 Financials
    • 5.2.11.5 Recent Developments
    • 5.2.11.6 Analyst Perception
  • 5.2.12 Stryker Corporation
    • 5.2.12.1 Company Overview
    • 5.2.12.2 Role of Stryker Corporation in the Deep Venous Disease Treatment Devices Market
    • 5.2.12.3 Product Portfolio
    • 5.2.12.4 Financials
    • 5.2.12.5 Analyst Perception
  • 5.2.13 Surmodics, Inc. (Vetex Medical Ltd.)
    • 5.2.13.1 Company Overview
    • 5.2.13.2 Role of Surmodics, Inc. in the Deep Venous Disease Treatment Devices Market
    • 5.2.13.3 Product Portfolio
    • 5.2.13.4 Financials
    • 5.2.13.5 Recent Developments
    • 5.2.13.6 Analyst Perception
  • 5.2.14 Teleflex Incorporated
    • 5.2.14.1 Company Overview
    • 5.2.14.2 Role of Teleflex Incorporated in the Deep Venous Disease Treatment Devices Market
    • 5.2.14.3 Product Portfolio
    • 5.2.14.4 Financials
    • 5.2.14.5 Recent Development
    • 5.2.14.6 Analyst Perception
  • 5.2.15 Terumo Corporation
    • 5.2.15.1 Company Overview
    • 5.2.15.2 Role of Terumo Corporation in the Deep Venous Disease Treatment Devices Market
    • 5.2.15.3 Product Portfolio
    • 5.2.15.4 Financials
    • 5.2.15.5 Recent Developments
    • 5.2.15.6 Analyst Perception

List of Figures

• Figure 1: Global Deep Venous Disease Treatment Devices Market, Impact Analysis
• Figure 2: Global Deep Venous Disease Treatment Devices Market (by Product), Share (%), 2022 and 2032
• Figure 3: Global Deep Venous Disease Treatment Devices Market (by Region), $Million, 2022 and 2032
• Figure 4: Global Deep Venous Disease Treatment Devices Market Segmentation
• Figure 5: Global Deep Venous Disease Treatment Devices Market: Research Methodology
• Figure 6: Primary Research Methodology
• Figure 7: Bottom-Up Approach (Segment-Wise Analysis)
• Figure 8: Top-Down Approach (Segment-Wise Analysis)
• Figure 9: Global Deep Venous Disease Treatment Devices Market Size and Growth Potential (Realistic Scenario), $Million, 2020-2032
• Figure 10: Global Deep Venous Disease Treatment Devices Market Size and Growth Potential (Optimistic Scenario), $Million, 2020-2032
• Figure 11: Global Deep Venous Disease Treatment Devices Market Size and Growth Potential (Pessimistic/Conservative Scenario), $Million, 2020-2032
• Figure 12: Regulatory and Legal Activities, January 2019-December 2022
• Figure 13: Global Deep Venous Disease Treatment Devices Market, Patent Analysis (by Year), January 2018-December 2022
• Figure 14: Global Deep Venous Disease Treatment Devices Market, Patent Analysis (by Country), January 2018-December 2022
• Figure 15: Deep Venous Disease Treatment Devices (Ongoing Clinical Trials), by Interventions, 2022
• Figure 16: Deep Venous Disease Treatment Devices (Ongoing Clinical Trials), by Company
• Figure 17: Global Deep Venous Disease Treatment Devices Market, Pre-COVID-19 Phase, $Million, 2020-2032
• Figure 18: Global Deep Venous Disease Treatment Devices Market, Impact Analysis
• Figure 19: Global Deep Vein Thrombosis and Pulmoanry EmbolismIncidences, 2017-2021
• Figure 20: Surgeries and Medical Procedures Considered to Increase the Risk of DVT
• Figure 21: FDA Approvals (Rivaroxaban, Apixaban, Dabigatran, Edoxaban, and Betrixaban Active Ingredients), 2017-2021
• Figure 22: Global Deep Venous Disease Treatment Devices Market (by Product)
• Figure 23: Global Deep Venous Disease Treatment Devices Market, Incremental Opportunity (by Product), $Million, 2022-2032
• Figure 24: Global Deep Venous Disease Treatment Devices Market, Growth-Share Matrix (by Product), 2022-2032
• Figure 25: Global Deep Venous Disease Treatment Devices Market (Thrombectomy and Thrombolysis Device), Market Dynamics
• Figure 26: Global Deep Venous Disease Treatment Devices Market (Thrombectomy and Thrombolysis Device), $Million, 2020-2032
• Figure 27: Global Deep Venous Disease Treatment Devices Market (Thrombectomy and Thrombolysis Device), by Device, $Million, 2020-2032
• Figure 28: Global Deep Venous Disease Treatment Devices Market (IVC Filter), Market Dynamics
• Figure 29: Global Deep Venous Disease Treatment Devices Market (Inferior Vena Cava Filter), $Million, 2020-2032
• Figure 30: Global Deep Venous Disease Treatment Devices Market (Inferior Vena Cava Filter), by Device, $Million, 2020-2032
• Figure 31: Global Deep Venous Disease Treatment Devices Market (Peripheral Vascular Stent), Market Dynamics
• Figure 32: Global Deep Venous Disease Treatment Devices Market (Peripheral Vascular Stent), $Million, 2020-2032
• Figure 33: Global Deep Venous Disease Treatment Devices Market (Peripheral Vascular Stent), by Type, $Million, 2020-2032
• Figure 34: Global Deep Venous Disease Treatment Devices Market (PTA Balloon Catheter), Market Dynamics
• Figure 35: Global Deep Venous Disease Treatment Devices Market (PTA Balloon Catheter), $Million, 2020-2032
• Figure 36: Global Deep Venous Disease Treatment Devices Market (PTA Balloon Catheter), by Material, $Million, 2020-2032
• Figure 37: Global Deep Venous Disease Treatment Devices Market (Accessory Device), $Million, 2020-2032
• Figure 38: Global Deep Venous Disease Treatment Devices Market (Accessory Device), by Type, $Million, 2020-2032
• Figure 39: Global Deep Venous Disease Treatment Devices Market (Compression Device/Stockings), Market Dynamics
• Figure 40: Global Deep Venous Disease Treatment Devices Market (Compression Device/Stockings), $Million, 2020-2032
• Figure 41: Global Deep Venous Disease Treatment Devices Market (by End User)
• Figure 42: Global Deep Venous Disease Treatment Devices Market Incremental Opportunity (by End User), $Million, 2022-2032
• Figure 43: Global Deep Venous Disease Treatment Devices Market, Growth-Share Matrix (by End User), 2022-2032
• Figure 44: Global Deep Venous Disease Treatment Devices Market (Hospitals and Clinics), $Million, 2020-2032
• Figure 45: Global Deep Venous Disease Treatment Devices Market (Ambulatory Surgery Centers), $Million, 2020-2032
• Figure 46: Global Deep Venous Disease Treatment Devices Market (Home-Care), $Million, 2020-2032
• Figure 47: Global Deep Venous Disease Treatment Devices Market Share and CAGR (by Region), 2022 and 2023-2032
• Figure 48: North America Deep Venous Disease Treatment Devices Market Incremental Opportunity (by Country), $Million, 2022-2032
• Figure 49: North America Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 50: North America Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 51: North America Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 52: North America Deep Venous Disease Treatment Devices Market (by Country), Share (%), 2022 and 2032
• Figure 53: Prevalence of Deep Vein Thrombosis (DVT) and Pulmonary Embolsim (PE) in the U.S., 2022
• Figure 54: U.S. Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 55: U.S. Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 56: U.S. Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 57: Canada Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 58: Canada Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 59: Canada Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 60: Europe Deep Venous Disease Treatment Devices Market Incremental Opportunity (by Country), $Million, 2022-2032
• Figure 61: Europe Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 62: Europe Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 63: Europe Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 64: Europe Deep Venous Disease Treatment Devices Market (by Country), Share (%), 2022 and 2032
• Figure 65: Germany Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 66: Germany Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 67: Germany Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 68: U.K. Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 69: U.K. Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 70: U.K. Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 71: France Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 72: France Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 73: France Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 74: Italy Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 75: Italy Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 76: Italy Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 77: Spain Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 78: Spain Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 79: Spain Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 80: Rest-of-Europe Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 81: Rest-of-Europe Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 82: Rest-of-Europe Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 83: Asia-Pacific Deep Venous Disease Treatment Devices Market Incremental Opportunity (by Country), $Million, 2022-2032
• Figure 84: Asia-Pacific Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 85: Asia-Pacific Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 86: Asia-Pacific Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 87: Asia-Pacific Deep Venous Disease Treatment Devices Market (by Country), Share (%), 2022 and 2032
• Figure 88: Japan Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 89: Japan Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 90: Japan Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 91: China Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 92: China Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 93: China Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 94: India Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 95: India Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 96: India Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 97: Australia Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 98: Australia Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 99: Australia Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 100: South Korea Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 101: South Korea Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 102: South Korea Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 103: Rest-of-Asia-Pacific Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 104: Rest-of-Asia-Pacific Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 105: Rest-of-Asia-Pacific Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 106: Rest-of-the-World Deep Venous Disease Treatment Devices Market Incremental Opportunity (by Country), $Million, 2022-2032
• Figure 107: Rest-of-the-World Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 108: Rest-of-the-World Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 109: Rest-of-the-World Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 110: Rest-of-the-World Deep Venous Disease Treatment Devices Market (by Country), Share (%), 2022 and 2032
• Figure 111: Brazil Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 112: Brazil Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 113: Brazil Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 114: South Africa Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 115: South Africa Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 116: South Africa Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 117: Rest-of-Rest-of-the-World Deep Venous Disease Treatment Devices Market, $Million, 2020-2032
• Figure 118: Rest-of-Rest-of-the-World America Deep Venous Disease Treatment Devices Market (by Product Type), $Million, 2020-2032
• Figure 119: Rest-of-Rest-of-the-World Deep Venous Disease Treatment Devices Market (by End User), $Million, 2020-2032
• Figure 120: Share of Key Developments and Strategies, January 2019-January 2023
• Figure 121: Regulatory and Legal Activities (by Company), January 2019-January 2023
• Figure 122: Partnerships, Alliances, and Business Expansions (by Company), January 2019-January 2023
• Figure 123: New Offerings (by Company), January 2019-January 2023
• Figure 124: Mergers and Acquisitions (by Company), January 2019-January 2023
• Figure 125: Funding Activities (by Company), January 2019-January 2023
• Figure 126: Key Development Analysis (Heat Map), January 2019-January 2023
• Figure 127: Abbott Laboratories: Overall Product Portfolio
• Figure 128: Abbott Laboratories: Overall Financials, $Million, 2019-2021
• Figure 129: Abbott Laboratories: Net Revenue (by Business Segment), $Million, 2019-2021
• Figure 130: Abbott Laboratories: Net Revenue (by Region), $Million, 2019-2021
• Figure 131: Abbott Laboratories: R&D Expenditure, $Million, 2019-2021
• Figure 132: AndraTec GmbH: Overall Product Portfolio
• Figure 133: AngioDynamics, Inc.: Overall Product Portfolio
• Figure 134: AngioDynamics, Inc.: Overall Financials, $Million, 2020-2022
• Figure 135: AngioDynamics, Inc.: Revenue (by Segment), $Million, 2020-2022
• Figure 136: AngioDynamics, Inc.: Revenue (by Region), $Million, 2020-2022
• Figure 137: AngioDynamics, Inc.: R&D Expense, $Million, 2020-2022
• Figure 138: Boston Scientific Corporation: Overall Product Portfolio
• Figure 139: Boston Scientific Corporation: Overall Financials, $Million, 2019-2021
• Figure 140: Boston Scientific Corporation: Revenue (by Segment), $Million, 2019-2021
• Figure 141: Boston Scientific Corporation: R&D Expense, $Million, 2019-2021
• Figure 142: Cardinal Health: Overall Product Portfolio
• Figure 143: Cardinal Health: Overall Financials, $Million, 2020-2022
• Figure 144: Cardinal Health: Revenue (by Segment), $Million, 2020-2022
• Figure 145: Cardinal Health: Revenue (by Region), $Million, 2020-2022
• Figure 146: Cook Group: Overall Product Portfolio
• Figure 147: Koninklijke Philips N.V.: Product Portfolio
• Figure 148: Koninklijke Philips N.V.: Overall Financials, $Million, 2019-2021
• Figure 149: Koninklijke Philips N.V.: Revenue (by Segment), $Million, 2019-2021
• Figure 150: Koninklijke Philips N.V.: Revenue (by Region), $Million, 2019-2021
• Figure 151: Koninklijke Philips N.V.: R&D Expenditure, $Million, 2019-2021
• Figure 152: Medtronic plc: Overall Product Portfolio
• Figure 153: Medtronic plc: Overall Financials, $Million, 2020-2022
• Figure 154: Medtronic plc: Revenue (by Segment), $Million, 2020-2022
• Figure 155: Medtronic plc: Revenue (by Region), $Million 2020-2022
• Figure 156: Medtronic plc: R&D Expense, $Million, 2020-2022
• Figure 157: Nipro Corporation: Overall Product Portfolio
• Figure 158: Nipro Corporation: Overall Financials, $Million, 2020-2022
• Figure 159: Nipro Corporation: Revenue (by Segment), $Million, 2020-2022
• Figure 160: Nipro Corporation: R&D Expense, $Million, 2020-2022
• Figure 161: Penumbra, Inc.: Overall Product Portfolio
• Figure 162: Penumbra, Inc.: Overall Financials, $Million, 2019-2021
• Figure 163: Penumbra, Inc.: Revenue (by Segment), $Million, 2019-2021
• Figure 164: Penumbra, Inc.: Revenue (by Region), $Million 2019-2021
• Figure 165: Penumbra, Inc.: R&D Expense, $Million, 2019-2021
• Figure 166: Stryker Corporation: Overall Product Portfolio
• Figure 167: Stryker Corporation: Overall Financials, $Million, 2019-2021
• Figure 168: Stryker Corporation: Revenue (by Segment), $Million, 2019-2021
• Figure 169: Stryker Corporation: Subsegment Revenue (MedSurg and Neurotechnology), $Million 2019-2021
• Figure 170: Stryker Corporation: Revenue (by Region), $Million 2019-2021
• Figure 171: Stryker Corporation: R&D Expense, $Million, 2019-2021
• Figure 172: Surmodics, Inc.: Overall Product Portfolio
• Figure 173: Surmodics, Inc.: Overall Financials, $Million, 2020-2022
• Figure 174: Surmodics, Inc.: Revenue (by Segment), $Million, 2020-2022
• Figure 175: Surmodics, Inc.: R&D Expense, $Million, 2020-2022
• Figure 176: Teleflex Incorporated: Overall Product Portfolio
• Figure 177: Teleflex Incorporated: Overall Financials, $Million, 2019-2021
• Figure 178: Teleflex Incorporated: Revenue (by Segment), $Million, 2019-2021
• Figure 179: Teleflex Incorporated: Revenue (by Region), $Million 2019-2021
• Figure 180: Teleflex Incorporated: R&D Expense, $Million, 2019-2021
• Figure 181: Terumo Corporation: Overall Product Portfolio
• Figure 182: Terumo Corporation: Overall Financials, $Million, 2020-2022
• Figure 183: Terumo Corporation: Revenue (by Segment), $Million, 2020-2022
• Figure 184: Terumo Corporation: Revenue (by Region), $Million 2020-2022

List of Tables

• Table 1: Global Deep Venous Disease Treatment Devices Market, Quarterly Key Developments Analysis, January 2018-January 2023
• Table 2: Key Questions Answered in the Report
• Table 3: Parameters for Realistic, Optimistic, and Pessimistic Growth Scenarios
• Table 4: Global Deep Venous Disease Treatment Devices Market, Product Benchmarking
• Table 5: Global Deep Venous Disease Treatment Devices Market, Pipeline Companies
• Table 6: Global Deep Venous Disease Treatment Devices (by Thrombectomy and Thrombolysis Device), Heat Map
• Table 7: Global Deep Venous Disease Treatment Devices (by IVC Filter), Heat Map
• Table 8: Global Deep Venous Disease Treatment Devices (by Peripheral Vascular Stent), Heat Map
• Table 9: Global Deep Venous Disease Treatment Devices (by PTA Balloon Catheter), Heat Map
• Table 10: Global Deep Venous Disease Treatment Devices (by Accessory Device), Heat Map
• Table 11: Global Deep Venous Disease Treatment Devices (by Compression Device/Stockings), Heat Map
• Table 12: North America Deep Venous Disease Treatment Devices Market, Impact Analysis
• Table 13: Recalls for Deep Venous Disease Treatment Devices by the U.S. Food and Drug Administration (FDA)
• Table 14: Europe Deep Venous Disease Treatment Devices Market, Impact Analysis
• Table 15: Asia-Pacific Deep Venous Disease Treatment Devices Market, Impact Analysis
• Table 16: Rest-of-the-World Deep Venous Disease Treatment Devices Market, Impact Analysis
• Table 17: Abbott Laboratories.: Key Products and Features
• Table 18: AndraTec GmbH: Key Products and Features
• Table 19: AngioDynamics, Inc.: Key Products and Features
• Table 20: Boston Scientific Corporation: Key Products and Features
• Table 21: Cardinal Health: Key Products and Features
• Table 22: Cook Group: Key Products and Features
• Table 23: Koninklijke Philips N.V.: Key Products and Features
• Table 24: Medtronic plc: Key Products and Features
• Table 25: Nipro Corporation: Key Products and Features
• Table 26: Penumbra, Inc.: Key Products and Features
• Table 27: Stryker Corporation: Key Products and Features
• Table 28: Surmodics, Inc.: Key Products and Features
• Table 29: Teleflex Incorporated: Key Products and Features
• Table 30: Terumo Corporation: Key Products and Features